CAS 1883518-31-7

GNE-0723

CAS : 1883518-31-7

Formule : C₁₆H₈ClF₆N₅OS

Masse moléculaire : 467.77

Ref: 4Z-G-172001

GNE-0723

CAS : 1883518-31-7

GNE-0723 is a novel allosteric modulator that enhances synaptic function. GNE-0723 binds to the NMDA receptor and potentiates the activity of glutamate, an excitatory neurotransmitter that plays a major role in synaptic plasticity. This drug has been shown to produce antidepressant-like effects in mice, which may be due to its ability to increase levels of brain-derived neurotrophic factor (BDNF) and synaptogenesis. GNE-0723 also inhibits the activity of GABA receptors, which can lead to sedative effects. 3-Desacetylcefotaxime potassium Rifapentine Tilmicosin Gatifloxacin

Formule : C₁₆H₈ClF₆N₅OS

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 467.8 g/mol

Ref: 3D-IAD51831

GNE-0723

CAS : 1883518-31-7

GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, GluN2A.blood-brain barrier (BBB) and Dravet syndrome and Alzheimer's disease (AD).

Formule : C₁₆H₈ClF₆N₅OS

Degré de pureté : 97.29% - 99.91%

Couleur et forme : Solid

Masse moléculaire : 467.78

Ref: TM-T15407